{"id":"NCT01987479","sponsor":"Hoffmann-La Roche","briefTitle":"A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis","officialTitle":"Multi-Center, Open Label, Single Arm Phase IIIB Study on Safety and Efficacy of Subcutaneous Tocilizumab in Monotherapy or in Combination With Methotrexate or Other Non-Biologic Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients With an Inadequate Response to Non-Biologic DMARDs - OSCAR","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-30","primaryCompletion":"2016-05-26","completion":"2016-05-26","firstPosted":"2013-11-19","resultsPosted":"2017-06-19","lastUpdate":"2017-06-19"},"enrollment":150,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Non-Biologic DMARDs","otherNames":[]},{"type":"DRUG","name":"Tocilizumab","otherNames":["RoActemra, Actemra"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]}],"arms":[{"label":"Tocilizumab Alone or in Combination with Methotrexate or DMARD","type":"EXPERIMENTAL"}],"summary":"This multi-center, open-label single arm Phase IIIb study will evaluate the safety and efficacy of subcutaneous (SC) tocilizumab administered as monotherapy and/or in combination with methotrexate or other non-biologic disease modifying antirheumatic drugs (DMARDs) in participants with rheumatoid arthritis (RA) with an inadequate response to non-biologic DMARDs.","primaryOutcome":{"measure":"Percentage of Participants With Adverse Events","timeFrame":"Baseline up to Week 32","effectByArm":[{"arm":"Tocilizumab Alone or in Combination With Methotrexate or DMARD","deltaMin":91.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":20},"locations":{"siteCount":20,"countries":["Netherlands"]},"refs":{"pmids":["30649524","29244149"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":150},"commonTop":["Nasopharyngitis","Nausea","Fatigue","Dizziness","Diarrhoea"]}}